Gen XY Updates from GlobeNewswire
2025-10-16T16:01:25Z
Revenue up 11.7% in the third quarter
2025-10-16T16:00:00Z
Ghent, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
2025-10-16T15:45:00Z
Press release on October 16, 2025, after market close at 5:45 p.m. CEST
2025-10-16T15:00:00Z
BERKELEY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointments of Tara Murphy...
2025-10-16T14:53:23Z
TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- This weekend, Toronto will once again host Canada’s premier running event: the TCS Toronto Waterfront Marathon. The internationally renowned event brings together more...
2025-10-16T14:45:00Z
CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- It's official: Pickleball fever has swept the nation, and the YMCA is proudly at the center of the craze.
2025-10-16T14:20:00Z
Sign up for an Iconic Road-cycling Experience against Hong Kong’s Skyline
2025-10-16T13:25:53Z
MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan...
2025-10-16T13:15:42Z
Company poster presentations will debut research data of three lead drug candidates constructed with Company’s novel TRBC platform technology
2025-10-16T13:15:00Z
THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it...
2025-10-16T13:05:00Z
Live webcast presentation on Tuesday, October 21st at 11:35 AM ET
2025-10-16T13:02:00Z
Innovative solution that is ideal for wipes, diapers, hygiene, and beauty applications, offering enhanced performance and sustainability
2025-10-16T13:01:00Z
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2025 results on Thursday,...
2025-10-16T13:00:00Z
Will Showcase Latest Fertility Solutions
2025-10-16T13:00:00Z
LONDON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Squawka today released a data-led analysis that dives into how Premier League clubs perform in their first league match immediately after international breaks...
2025-10-16T13:00:00Z
Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets
2025-10-16T13:00:00Z
IRVINE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host...
2025-10-16T13:00:00Z
COSTA MESA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (“El Pollo Loco”) (NASDAQ: LOCO) today announced that it will host a conference call to discuss...
2025-10-16T12:45:00Z
First-time presentation examining bone outcomes in early postmenopausal women
2025-10-16T12:45:00Z
International Myeloma Foundation (IMF) to hold AMN Awards Ceremony at the 9th AMN Summit in Nagoya, Japan on Saturday, October 18.
2025-10-16T12:30:00Z
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver...
2025-10-16T12:30:00Z
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices...
2025-10-16T12:30:00Z
Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the BreastCheck®
2025-10-16T12:30:00Z
Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience
2025-10-16T12:30:00Z
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System
2025-10-16T12:30:00Z
LONDON and NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular...
2025-10-16T12:19:00Z
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica’s Commercialization Strategy
2025-10-16T12:11:13Z
ROCKVILLE, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases...
2025-10-16T12:05:00Z
BELTSVILLE, Md. and SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, and Simcere Zaiming, an...
2025-10-16T12:05:00Z
NEEDHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help...
2025-10-16T12:00:00Z
FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac...
2025-10-16T12:00:00Z
Fort Lee, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment...
2025-10-16T12:00:00Z
MINNEAPOLIS, Oct. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc., a wholly-owned subsidiary of PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW) and an emerging biomedical device company focused on...
2025-10-16T12:00:00Z
Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients responding with telitacicept versus 32.7% with placebo
2025-10-16T12:00:00Z
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes
2025-10-16T12:00:00Z
SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases...
2025-10-16T12:00:00Z
MINNEAPOLIS, MN, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world’s largest corporate holders of Ether (“ETH”) and prominent industry...
2025-10-16T12:00:00Z
Company underscores clinical execution and confirms advanced negotiations underway on acquisition of complementary oncology assets
2025-10-16T12:00:00Z
CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that on October 15, 2025,...
2025-10-16T12:00:00Z
Canada’s biggest snow sports event returns October 24–26 with fresh energy, athlete inspiration, and an open invitation to all
2025-10-16T11:30:00Z
Data from Phase 1/2 TUSCANY trial presented at the European School of Haematology (ESH) 7th International Conference
2025-10-16T11:08:21Z
$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in Combination...
2025-10-16T11:00:00Z
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function
2025-10-16T11:00:00Z
CAMBRIDGE, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the company will...
2025-10-16T11:00:00Z
TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging...
2025-10-16T11:00:00Z
HYPHEN features brand new best-in-class technology that allows consumers to flex between extracts, size formats and brands through interchangeable vape pods
2025-10-16T11:00:00Z
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation...
2025-10-16T11:00:00Z
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the...
2025-10-16T11:00:00Z
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics, today announced that its founding discovery laboratory at the University...
2025-10-16T11:00:00Z
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving...
